Revisiting the physiology of nausea and vomiting-challenging the paradigm.
Gut-brain axis
Insular cortex
Interoception
Nausea
Vomiting
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
10
06
2019
accepted:
24
07
2019
pubmed:
8
8
2019
medline:
26
2
2020
entrez:
8
8
2019
Statut:
ppublish
Résumé
The predominant neurotransmitters and receptors for acute and delayed chemotherapy-induced nausea and vomiting (CINV) are represented in the current paradigm, which reflects successful control of emesis. However, control of nausea (N) lags behind management of vomiting (V). This review aims to re-examine and incorporate new information about the mechanisms of V and N. The initial literature search focused on CINV. Keywords in articles led to subsequent discovery of publications focused on N&V in other medical and scientific fields (e.g., gastroenterology, neurology, cannabinoid science, neuropharmacology, and motion sickness). Using keywords to identify other sources continued until no further recent, meaningful publications were found. More than 86% of references were from recent non-oncology journals and books, suggesting there are many areas for cross-fertilization research into mechanisms and management of N&V-particularly of N, which involves overlapping and dissimilar CNS areas from V. Information from cited articles was incorporated into visual representation of N&V, which is certainly not exhaustive but supports highly complex processes in the stomach and gut, the vagus nerve and spinal cord neurons, the nucleus tractus solitarii, and the anterior insular cortex and anterior cingulate cortex with input from the amygdala. These data support the idea that mechanisms for N, whatever the cause, must be highly similar. Continued research into nausea, including patient-reported evaluation and outcomes, is important; interventions for nausea could be considered adjuvants to current standard of care antiemetics and be individualized, depending on patient-reported efficacy and adverse effects and preferences.
Identifiants
pubmed: 31388745
doi: 10.1007/s00520-019-05012-8
pii: 10.1007/s00520-019-05012-8
doi:
Substances chimiques
Antiemetics
0
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
13-21Références
Aapro M (2018) CINV: still troubling patients after all these years. Support Care Cancer 26(suppl 1):S5–S9. https://doi.org/10.1007/s00520-018-4131-3
doi: 10.1007/s00520-018-4131-3
Childs DS, Looker S, Le-Rademacher J et al (2019) What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study. Support Care Cancer 27:249–255. https://doi.org/10.1007/s00520-018-4323-x
doi: 10.1007/s00520-018-4323-x
pubmed: 29938306
Singh P, Yoon SS, Kuo B (2016) Nausea: a review of pathophysiology and therapeutics. Ther Adv Gastroenterol 9:98–112. https://doi.org/10.1177/1756283X15618131
doi: 10.1177/1756283X15618131
Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC (2016) Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis. Support Care Cancer 24:2635–2642. https://doi.org/10.1007/s00520-015-3071-4
doi: 10.1007/s00520-015-3071-4
pubmed: 26746209
pmcid: 4846512
Ng TL, Hutton B, Clemons M (2015) Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist 20:576–583. https://doi.org/10.1634/theoncologist.2014-0438
doi: 10.1634/theoncologist.2014-0438
pubmed: 25948677
pmcid: 4571780
Harder SL, Groenvold M, Herrstedt J, Johnsen AT (2019) Nausea in advanced cancer: relationships between intensity, burden, and the need for help. Support Care Cancer 27:265–273. https://doi.org/10.1007/s00520-018-4326-7
doi: 10.1007/s00520-018-4326-7
pubmed: 29946792
Horn CC (2014) The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting. Curr Pharm Des 20:2703–2712. https://doi.org/10.2174/13816128113199990568
doi: 10.2174/13816128113199990568
pubmed: 23886386
Torres CH, Mazzarello S, Ng T et al (2015) Defining optimal control of chemotherapy-induced nausea and vomiting—based on patients’ experience. Support Care Cancer 23:3341–3359. https://doi.org/10.1007/s00520-015-2801-y
doi: 10.1007/s00520-015-2801-y
Limebeer CL, Rock EM, Sharkey KA, Parker LA (2018) Nausea-induced 5-HT release in the interoceptive insular cortex and regulation by monoacylglycerol lipase (MAGL) inhibition and cannabidiol. eNeuro 5(4). https://doi.org/10.1523/ENEURO.0256-18.2018
doi: 10.1523/ENEURO.0256-18.2018
Sanger GJ, Andrews PLR (2018) A history of drug discovery for treatment of nausea and vomiting and the implications for future research. Front Pharmacol 9:913. Published online Sept 4, 2018. https://doi.org/10.3389/fphar.2018.00913
doi: 10.3389/fphar.2018.00913
pubmed: 30233361
pmcid: 6131675
Balaban CD, Yates BJ (2017) What is nausea? A historical analysis of changing views. Auton Neurosci 202:5–17. https://doi.org/10.1016/j.autneu.2016.07.003
doi: 10.1016/j.autneu.2016.07.003
pubmed: 27450627
Napadow V, Sheehan JD, Kim J, LaCount LT, Park K, Kaptchuk TJ, Rosen BR, Kuo B (2013) The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex 23:806–813. https://doi.org/10.1093/cercor/bhs073
doi: 10.1093/cercor/bhs073
pubmed: 22473843
Koch KL (2014) Gastric dysrhythmias: a potential objective measure of nausea. Exp Brain Res 232:2553–2561. https://doi.org/10.1007/s00221-014-4007-9
doi: 10.1007/s00221-014-4007-9
pubmed: 24916149
Müller TD, Nogueiras R, Andermann ML (2015) Ghrelin. Molecular Metabolism 4:437–460. https://doi.org/10.1016/j.molmet.2015.03.005
doi: 10.1016/j.molmet.2015.03.005
pubmed: 26042199
pmcid: 4443295
Hiura Y, Takiguchi S, Yamamoto K, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, Doki Y (2012) Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol 17:316–323. https://doi.org/10.1007/s10147-011-0289-0
doi: 10.1007/s10147-011-0289-0
pubmed: 21773688
Wo JM, Ejskjaer N, Hellstrom PM et al (2011) Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting – randomised clinical study subset data. Aliment Pharmacol Ther 33:679–688. https://doi.org/10.1111/j.1365-2036.2010.04567.x
doi: 10.1111/j.1365-2036.2010.04567.x
pubmed: 21214610
Rudd JA, Chan SW, Ngan MP, Tu L, Lu Z, Giuliano C, Lovati E, Pietra C (2018) Anti-emetic action of the brain-penetrating new ghrelin agonist, HM01, alone and in combination with the 5-HT3 antagonist, palonosetron and with the NK1 antagonist, netupitant, against cisplatin- and motion-induced emesis in Suncus murinus (house musk shrew). Front Pharmacol 9:869. https://doi.org/10.3389/fphar.2018.00869
doi: 10.3389/fphar.2018.00869
pubmed: 30127745
pmcid: 6087754
Cabezos PA, Vera G, Martin-Fontelles MI et al (2010) Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica. Neurogastroenterol Motil 22:797–805, 797-e225. https://doi.org/10.1111/j.1365-2982.2010.01483.x
doi: 10.1111/j.1365-2982.2010.01483.x
pubmed: 20236245
Rock EM, Sticht MA, Limebeer CL, Parker LA (2016) Cannabinoid regulation of acute and anticipatory nausea. Cannabis Cannabinoid Res 1:113–121. https://doi.org/10.1089/can.2016.0006
doi: 10.1089/can.2016.0006
pubmed: 28861486
pmcid: 5576606
Weltens N, Iven J, Van Oudenhove L, Kano M (2018) The gut–brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci 1428:129–150. https://doi.org/10.1111/nyas.13969
doi: 10.1111/nyas.13969
pubmed: 30255954
Schemann M (2005) Control of gastrointestinal motility by the “gut brain” — the enteric nervous system. J Pediatr Gastroenterol Nutr 41:S4–S6
doi: 10.1097/01.scs.0000180285.51365.55
Critchley HD, Harrison NA (2013) Visceral influences on brain and behavior. Neuron 77:624–638. https://doi.org/10.1016/j.neuron.2013.02.008
doi: 10.1016/j.neuron.2013.02.008
pubmed: 23439117
Ahlman H, Nilsson O (2001) The gut as the largest endocrine organ in the body. Ann Oncol 12(Suppl 2):S63–S68
doi: 10.1093/annonc/12.suppl_2.S63
Nezami BG, Srinivasan S (2010) Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep 12:358–365. https://doi.org/10.1007/s11894-010-0129-9
doi: 10.1007/s11894-010-0129-9
pubmed: 20725870
pmcid: 3752592
Bellono NW, Bayrer JR, Leitch DB, Castro J, Zhang C, O’Donnell TA, Brierley SM, Ingraham HA, Julius D (2017) Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170:185–198. https://doi.org/10.1016/j.cell.2017.05.034
doi: 10.1016/j.cell.2017.05.034
pubmed: 28648659
pmcid: 5839326
Diwakarla S, Fothergill LJ, Fakhry J, Callaghan B, Furness JB (2017) Heterogeneity of enterochromaffin cells within the gastrointestinal tract. Neurogastroenterol Motil 29:e13101–ee1315. https://doi.org/10.1111/nmo.13101
doi: 10.1111/nmo.13101
Obara Y, Machida T, Takano Y, Shiga S, Suzuki A, Hamaue N, Iizuka K, Hirafuji M (2018) Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine. Naunyn Schmiedeberg's Arch Pharmacol 391:847–858. https://doi.org/10.1007/s00210-018-1493-5
doi: 10.1007/s00210-018-1493-5
Alcaino C, Knutson KR, Treichel AJ, Yildiz G, Strege PR, Linden DR, Li JH, Leiter AB, Szurszewski JH, Farrugia G, Beyder A (2018) A population of gut epithelial enterochromaffin cells is mechanosensitive and requires Piezo2 to convert force into serotonin release. Proc Natl Acad Sci U S A 115(32):E7632–E7641. https://doi.org/10.1073/pnas.1804938115
doi: 10.1073/pnas.1804938115
pubmed: 30037999
pmcid: 6094143
Babic T, Browning KN (2014) The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol 722:38–47. https://doi.org/10.1016/j.ejphar.2013.08.047
doi: 10.1016/j.ejphar.2013.08.047
pubmed: 24184670
Zhong W, Picca AJ, Lee AS, Darmani NA (2017) Ca2+ signaling and emesis: recent progress and new perspectives. Auton Neurosci 202:18–27. https://doi.org/10.1016/j.autneu.2016.07.006
doi: 10.1016/j.autneu.2016.07.006
pubmed: 27473611
Yamamoto K, Asano K, Tasaka A, Ogura Y, Kim S, Ito Y, Yamatodani A (2014) Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats. Brit J Pharmacol 171:2888–2899. https://doi.org/10.1111/bph.12629
doi: 10.1111/bph.12629
Ju C, Hamaue N, Machida T, Liu Y, Iizuka K, Wang Y, Minami M, Hirafuji M (2008) Anti-inflammatory drugs ameliorate opposite enzymatic changes in ileal 5-hydroxytryptamine metabolism in the delayed phase after cisplatin administration to rats. Eur J Pharmacol 589:281–287. https://doi.org/10.1016/j.ejphar.2008.04.050
doi: 10.1016/j.ejphar.2008.04.050
pubmed: 18534574
Machida T, Takano Y, Iizuka K, Machida M, Hirafuji M (2017) Methotrexate causes acute hyperplasia of enterochromaffin cells containing substance P in the intestinal mucosa of rats. J Pharmacol Sci 133:190–193. https://doi.org/10.1016/j.jphs.2017.02.009
doi: 10.1016/j.jphs.2017.02.009
pubmed: 28286019
Travagli RA, Anselmi L (2016) Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol 13:389–401. https://doi.org/10.1038/nrgastro.2016.76
doi: 10.1038/nrgastro.2016.76
pubmed: 27251213
pmcid: 5605144
Muth ER (2006) Motion and space sickness: intestinal and autonomic correlates. Auton Neurosci 129(1-2):58–66. https://doi.org/10.1016/j.autneu.2006.07.020
doi: 10.1016/j.autneu.2006.07.020
pubmed: 16950658
Lackner JR (2014) Motion sickness: more than nausea and vomiting. Exp Brain Res 232:2493–2510. https://doi.org/10.1007/s00221-014-4008-8
doi: 10.1007/s00221-014-4008-8
pubmed: 24961738
pmcid: 4112051
Toschi N, Kim J, Sclocco R, Duggento A, Barbieri R, Kuo B, Napadow V (2017) Motion sickness increases functional connectivity between visual motion and nausea-associated brain regions. Auton Neurosci 202:108–113. https://doi.org/10.1016/j.autneu.2016.10.003
doi: 10.1016/j.autneu.2016.10.003
pubmed: 28245927
Cutsforth-Gregory JK, Benarroch EE (2017) Nucleus of the solitary tract, medullary reflexes, and clinical implications. Neurology 88:1187–1196. https://doi.org/10.1212/WNL.0000000000003751
doi: 10.1212/WNL.0000000000003751
pubmed: 28202704
Kaur C, Ling E-A (2017) The circumventricular organs. Histol Histopathol 32:879–892. https://doi.org/10.14670/HH-11-881
doi: 10.14670/HH-11-881
pubmed: 28177105
Price CJ, Hoyda TD, Ferguson AV (2008) The area postrema: a brain monitor and integrator of systemic autonomic state. Neuroscientist 14:182–194. https://doi.org/10.1177/1073858407311100
doi: 10.1177/1073858407311100
pubmed: 18079557
Miyata S (2015) New aspects in fenestrated capillary and tissue dynamics in the sensory circumventricular organs of adult brains. Front Neurosci 9:–390. https://doi.org/10.3389/fnins.2015.00390
Wang Q-P, Guan J-L, Pan W, Kastin AJ, Shioda S (2008) A diffusion barrier between the area postrema and nucleus tractus solitarius. Neurochem Res 33:2035–2043. https://doi.org/10.1007/s11064-008-9676-y
doi: 10.1007/s11064-008-9676-y
pubmed: 18373195
Chin C-L, Fox GB, Hradil VP et al (2006) Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesis. NeuroImage 33:1152–1160. https://doi.org/10.1124/jpet.111.188797
doi: 10.1124/jpet.111.188797
pubmed: 17023182
Craig AD (2015) How do you feel? (pp 130–181). Princeton University Press
Sun X, Xu L, Guo F, Luo W, Gao S, Luan X (2017) Neurokinin-1 receptor blocker CP-99 94 improved emesis induced by cisplatin via regulating the activity of gastric distention responsive neurons in the dorsal motor nucleus of vagus and enhancing gastric motility in rats. Neurogastroenterol Motil 29(10):1–11. https://doi.org/10.1111/nmo.13096
doi: 10.1111/nmo.13096
pubmed: 28464353
Stich MA, Limebeer CL, Rafla BR et al (2016) Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. Neuropharmacol 102:92–102. https://doi.org/10.1016/j.neuropharm.2015.10.039
doi: 10.1016/j.neuropharm.2015.10.039
Farmer AD, Ban VF, Coen SJ, Sanger GJ, Barker GJ, Gresty MA, Giampietro VP, Williams SC, Webb DL, Hellström PM, Andrews PLR, Aziz Q (2015) Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans. J Physiol 593(5):1183–1196. https://doi.org/10.1113/jphysiol.2014.284240
doi: 10.1113/jphysiol.2014.284240
pubmed: 25557265
pmcid: 4358679
Sclocco R, Kim J, Garcia RG, Sheehan JD, Beissner F, Bianchi AM, Cerutti S, Kuo B, Barbieri R, Napadow V (2016) Brain circuitry supporting multi-organ autonomic outflow in response to nausea. Cereb Cortex 26:485–497. https://doi.org/10.1093/cercor/bhu172
doi: 10.1093/cercor/bhu172
pubmed: 25115821
Uddin LQ, Nomi JS, Hebert-Seropian B et al (2017) Structure and function of the human insula. J Clin Neurophysiol 34:300–306. https://doi.org/10.1097/WNP.0000000000000377
doi: 10.1097/WNP.0000000000000377
pubmed: 28644199
pmcid: 6032992
Namkung H, Kim S-H, Sawa A (2017) The insula: an underestimated brain area in clinical neuroscience, psychiatry, and neurology. Trends Neurosci 40:200–207. https://doi.org/10.1016/j.tins.2017.02.002
doi: 10.1016/j.tins.2017.02.002
pubmed: 28314446
pmcid: 5538352
Gogolla N (2017) The insular cortex. Curr Biol 27:R573–R591. https://doi.org/10.1016/j.cub.2017.05.010
doi: 10.1016/j.cub.2017.05.010
Craig AD (2009) How do you feel — now? The anterior insula and human awareness. Nat Rev Neurosci 10:59–70. https://doi.org/10.1038/nrn2555
doi: 10.1038/nrn2555
pubmed: 19096369
Janak PH, Tye KM (2015) From circuits to behaviour in the amygdala. Nature 517(7534):284–292. https://doi.org/10.1038/nature14188
doi: 10.1038/nature14188
pubmed: 25592533
pmcid: 4565157
Benarroch EE (2016) Parabrachial nuclear complex: multiple functions and potential clinical implications. Neurology 86:676–683. https://doi.org/10.1212/WNL.0000000000002393
doi: 10.1212/WNL.0000000000002393
pubmed: 26791152
Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R (2013) Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 21:735–748. https://doi.org/10.1007/s00520-012-1574-9
doi: 10.1007/s00520-012-1574-9
pubmed: 22976921
Lu Y, Anderson HD (2017) Cannabinoid signaling in health and disease. Can J Physiol Pharmacol 95:311–327. https://doi.org/10.1139/cjpp-2016-0346
doi: 10.1139/cjpp-2016-0346
pubmed: 28263083
Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21–47. https://doi.org/10.1146/annurev-psych-113011-143739
doi: 10.1146/annurev-psych-113011-143739
pubmed: 22804774
Sharkey KA, Darmani NA, Parker LA (2014) Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 722:134–146. https://doi.org/10.1016/j.ejphar.2013.09.068
doi: 10.1016/j.ejphar.2013.09.068
pubmed: 24184696
Zheng Y, Wang X-L, Moa F-F, Li M (2014) Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. Eur J Pharmacol 727:99–105. https://doi.org/10.1016/j.ejphar.2014.01.047
doi: 10.1016/j.ejphar.2014.01.047
pubmed: 24508383
Smith LA, Azariah F, Lavender VTC, et al (2015). Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews Issue 11. Art. No.: CD009464. https://doi.org/10.1002/14651858.CD009464.pub2
Abrams DI (2018) The therapeutic effects of Cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med 49:7–11. https://doi.org/10.1016/j.ejim.2018.01.003
doi: 10.1016/j.ejim.2018.01.003
pubmed: 29325791
Farrell C, Brearley SG, Pilling M, Molassiotis A (2013) The impact of chemotherapy-related nausea on patients’ nutritional status, psychological distress and quality of life. Support Care Cancer 21:59–66. https://doi.org/10.1007/s00520-012-1493-9
doi: 10.1007/s00520-012-1493-9
pubmed: 22610269
Andrews PLR, Sanger GJ (2014) Nausea and the quest for the perfect anti-emetic. Eur J Pharmacol 722:108–121. https://doi.org/10.1016/j.ejphar.2013.09.072
doi: 10.1016/j.ejphar.2013.09.072
pubmed: 24157981
Malamood M, Roberts A, Kataria R, Parkman H, Schey R (2017) Mirtazapine for symptom control in refractory gastroparesis. Drug Des Devel Ther 11:1035–1041. https://doi.org/10.2147/DDDT.S125743
doi: 10.2147/DDDT.S125743
pubmed: 28408802
pmcid: 5384687